These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 17052779
1. Effect of folate supplementation on N-terminal pro-brain natriuretic peptide. Herrmann M, Stanger O, Paulweber B, Hufnagl C, Herrmann W. Int J Cardiol; 2007 May 31; 118(2):267-9. PubMed ID: 17052779 [Abstract] [Full Text] [Related]
2. Folate supplementation does not affect biochemical markers of bone turnover. Herrmann M, Stanger O, Paulweber B, Hufnagl C, Herrmann W. Clin Lab; 2006 May 31; 52(3-4):131-6. PubMed ID: 16584059 [Abstract] [Full Text] [Related]
3. Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in individuals with cerebrovascular disease. Campbell DJ, Woodward M, Chalmers JP, Colman SA, Jenkins AJ, Kemp BE, Neal BC, Patel A, MacMahon SW. J Hypertens; 2007 Mar 31; 25(3):699-705. PubMed ID: 17278987 [Abstract] [Full Text] [Related]
4. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. Toblli JE, Lombraña A, Duarte P, Di Gennaro F. J Am Coll Cardiol; 2007 Oct 23; 50(17):1657-65. PubMed ID: 17950147 [Abstract] [Full Text] [Related]
5. Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Scharhag J, Herrmann M, Urhausen A, Haschke M, Herrmann W, Kindermann W. Am Heart J; 2005 Dec 23; 150(6):1128-34. PubMed ID: 16338248 [Abstract] [Full Text] [Related]
6. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure. Zdrenghea D, Pop D, Ilea M, Bodisz G, Mălai A, Zdrenghea M. Rom J Intern Med; 2009 Dec 23; 47(1):35-40. PubMed ID: 19886067 [Abstract] [Full Text] [Related]
7. Effect of folate supplementation on serum homocysteine and plasma total antioxidant capacity in hypercholesterolemic adults under lovastatin treatment: a double-blind randomized controlled clinical trial. Shidfar F, Homayounfar R, Fereshtehnejad SM, Kalani A. Arch Med Res; 2009 Jul 23; 40(5):380-6. PubMed ID: 19766902 [Abstract] [Full Text] [Related]
8. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level. Toprak A, Erenus M, Ilhan AH, Haklar G, Fak AS, Oktay A. Climacteric; 2005 Sep 23; 8(3):279-86. PubMed ID: 16390760 [Abstract] [Full Text] [Related]
9. NT-proBNP in monitoring treatment of patients with congestive heart failure. Al-Meslmani BM, Fahoum SK, Shamia MG. Clin Lab; 2007 Sep 23; 53(1-2):35-9. PubMed ID: 17323823 [Abstract] [Full Text] [Related]
10. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay. Lee-Lewandrowski E, Januzzi JL, Green SM, Tannous B, Wu AH, Smith A, Wong A, Murakami MM, Kaczmarek J, Apple FS, Miller WL, Hartman K, Jaffe AS. Clin Chim Acta; 2007 Sep 23; 386(1-2):20-4. PubMed ID: 17854790 [Abstract] [Full Text] [Related]
11. The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure. Schou M, Gustafsson F, Corell P, Kistorp CN, Kjaer A, Hildebrandt PR. Am Heart J; 2007 Jul 23; 154(1):123-9. PubMed ID: 17584564 [Abstract] [Full Text] [Related]
12. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD. J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563 [Abstract] [Full Text] [Related]
13. [Change of N-terminal pro-brain natriuretic peptide and big endothelin in patients undergoing coronary artery bypass grafting]. Lu YF, Qi HW, Tang CZ, Wu MY, Wang Y, Zhao FH. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov 13; 19(11):667-70. PubMed ID: 17996134 [Abstract] [Full Text] [Related]
14. N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART. Berg T, Zdunek D, Stalke J, Dupke S, Baumgarten A, Carganico A, Hess G. Eur J Med Res; 2007 Apr 26; 12(4):152-60. PubMed ID: 17509959 [Abstract] [Full Text] [Related]
15. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats. Fox PR, Oyama MA, Reynolds C, Rush JE, DeFrancesco TC, Keene BW, Atkins CE, Macdonald KA, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Nguyenba TP, Lehmkuhl LB, Lefbom BK, Moise NS, Hogan DF. J Vet Cardiol; 2009 May 26; 11 Suppl 1():S51-61. PubMed ID: 19394287 [Abstract] [Full Text] [Related]
17. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis. David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D. Nephrol Dial Transplant; 2008 Apr 26; 23(4):1370-7. PubMed ID: 18089624 [Abstract] [Full Text] [Related]
18. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease]. Zhang SR, Zhang YH, Xu Q, Qiu HX, Chen Q. Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun 26; 11(6):429-32. PubMed ID: 19558803 [Abstract] [Full Text] [Related]
19. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea. Bayes-Genis A, Lloyd-Jones DM, van Kimmenade RR, Lainchbury JG, Richards AM, Ordoñez-Llanos J, Santaló M, Pinto YM, Januzzi JL. Arch Intern Med; 2007 Feb 26; 167(4):400-7. PubMed ID: 17325303 [Abstract] [Full Text] [Related]